Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Update on herpes zoster vaccination: a family practitioner's guide.

Shapiro M, Kvern B, Watson P, Guenther L, McElhaney J, McGeer A.

Can Fam Physician. 2011 Oct;57(10):1127-31. Review.

2.

Vaccination against herpes zoster in developed countries: state of the evidence.

Drolet M, Oxman MN, Levin MJ, Schmader KE, Johnson RW, Patrick D, Mansi JA, Brisson M.

Hum Vaccin Immunother. 2013 May;9(5):1177-84. doi: 10.4161/hv.23491. Epub 2013 Jan 16. Review.

3.

Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccination.

Johnson RW.

Aging Clin Exp Res. 2009 Jun;21(3):236-43. Review.

PMID:
19571648
4.

Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults.

Sanford M, Keating GM.

Drugs Aging. 2010 Feb 1;27(2):159-76. doi: 10.2165/10489140-000000000-00000. Review.

PMID:
20104941
5.

[Herpes Zoster and its prevention in Italy. Scientific consensus statement].

Franco E, Gabutti G, Bonanni P, Conversano M, Stefano Valente ME, Ferro A, Icardi G, Antonio Volpi ML, Maggi S, Rossi A, Scotti S, Vitale F, Greco D; Italian Universities and Epidemiology..

Ig Sanita Pubbl. 2014 Jan-Feb;70(1):111-27. Italian.

PMID:
24770367
6.

A systematic review of the cost effectiveness of herpes zoster vaccination.

Szucs TD, Pfeil AM.

Pharmacoeconomics. 2013 Feb;31(2):125-36. doi: 10.1007/s40273-012-0020-7. Review.

PMID:
23335045
7.

Vaccination: a new option to reduce the burden of herpes zoster.

Mick G.

Expert Rev Vaccines. 2010 Mar;9(3 Suppl):31-5. doi: 10.1586/erv.10.32. Review.

PMID:
20192716
8.

Herpes zoster: diagnostic, therapeutic, and preventive approaches.

Bader MS.

Postgrad Med. 2013 Sep;125(5):78-91. doi: 10.3810/pgm.2013.09.2703. Review.

PMID:
24113666
9.

Strategies for herpes zoster vaccination of immunocompromised patients.

Cohen JI.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S237-41. doi: 10.1086/522129. Review.

10.

[Prevention of herpes zoster by vaccination].

Kofoed K, Rønholt F, Gerstoft J, Sand C.

Ugeskr Laeger. 2011 Jan 10;173(2):110-4. Review. Danish.

PMID:
21219841
11.

Cost-effectiveness of vaccination against herpes zoster.

de Boer PT, Wilschut JC, Postma MJ.

Hum Vaccin Immunother. 2014;10(7):2048-61. doi: 10.4161/hv.28670. Review.

12.

A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.

Holcomb K, Weinberg JM.

J Drugs Dermatol. 2006 Oct;5(9):863-6. Review.

PMID:
17039651
13.

Varicella zoster virus redux.

Gelb LD.

Herpes. 2009 Jan;15(3):62-3. Review.

PMID:
19306605
14.

Herpes zoster virus vaccine.

Woolery WA.

Geriatrics. 2008 Oct;63(10):6-9. Review.

PMID:
18828650
15.

Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia.

Gilden D.

J Intern Med. 2011 May;269(5):496-506. doi: 10.1111/j.1365-2796.2011.02359.x. Epub 2011 Feb 23. Review.

16.

Zoster vaccine live.

Kockler DR, McCarthy MW.

Pharmacotherapy. 2007 Jul;27(7):1013-9. Review.

PMID:
17594207
17.

A novel vaccine (Zostavax) to prevent herpes zoster.

Holcomb K, Weinberg JM.

G Ital Dermatol Venereol. 2008 Apr;143(2):119-23. Review.

PMID:
18833038
18.

The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine.

Schmader K, Gnann JW Jr, Watson CP.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S207-15. doi: 10.1086/522152. Review.

PMID:
18419399
19.

Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.

Liesegang TJ.

Ophthalmology. 2008 Feb;115(2 Suppl):S3-12. doi: 10.1016/j.ophtha.2007.10.009. Review.

PMID:
18243930
20.

[Zoster vaccine].

Wutzler P.

Klin Monbl Augenheilkd. 2010 May;227(5):384-7. doi: 10.1055/s-0029-1245133. Epub 2010 May 20. Review. German.

PMID:
20490991

Supplemental Content

Support Center